Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Gains from Sales and Divestitures (2022)

Agilon Health (AGL) has disclosed Gains from Sales and Divestitures for 1 consecutive years, with $404000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Gains from Sales and Divestitures changed N/A year-over-year to $404000.0, compared with a TTM value of $404000.0 through Dec 2022, changed N/A, and an annual FY2022 reading of $404000.0, changed N/A over the prior year.
  • Gains from Sales and Divestitures was $404000.0 for Q4 2022 at Agilon Health.
  • Across five years, Gains from Sales and Divestitures topped out at $404000.0 in Q4 2022 and bottomed at $404000.0 in Q4 2022.